世界の筋層浸潤性膀胱がん治療市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Muscle Invasive Bladder Cancer Treatment Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-5259
• 出版社/出版日：QYResearch / 2021年6月
※2024年版があります。お問い合わせください。
• レポート形態：英文、PDF、97ページ
• 納品方法：Eメール（納期：3日）
• 産業分類：医療機器

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

レポート概要

QYResearch社発行の本調査レポートでは、筋層浸潤性膀胱がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（ネオアジュバント化学療法、術後化学療法）、用途別市場規模（病院、研究所、専門クリニック）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。
・市場概要
・筋層浸潤性膀胱がん治療の市場動向
・企業の競争状況、市場シェア
・筋層浸潤性膀胱がん治療の種類別市場規模と予測2016-2027（ネオアジュバント化学療法、術後化学療法）
・筋層浸潤性膀胱がん治療の用途別市場規模と予測2016-2027（病院、研究所、専門クリニック）
・筋層浸潤性膀胱がん治療の北米市場規模2016-2027（アメリカ、カナダ）
・筋層浸潤性膀胱がん治療の欧州市場規模2016-2027（ドイツ、フランス、イギリス等）
・筋層浸潤性膀胱がん治療のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等）
・筋層浸潤性膀胱がん治療の中南米市場規模2016-2027（メキシコ、ブラジル）
・筋層浸潤性膀胱がん治療の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等）
・主要企業情報（Pfizer Inc、Mylan N.V.、Cadila Pharmaceuticals、GLS pharma Ltd.、Accord Healthcare、Novartis AG、Cipla Inc.、Biochem Pharma）
・結論

Muscle invasive bladder cancer is treated by chemotherapy, radiation therapy, or a combination of the two, and anti-cancer treatment is carried out through drugs that kill cancer cells.

Market Analysis and Insights: Global Muscle Invasive Bladder Cancer Treatment Market
The global Muscle Invasive Bladder Cancer Treatment market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Muscle Invasive Bladder Cancer Treatment market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Muscle Invasive Bladder Cancer Treatment market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Muscle Invasive Bladder Cancer Treatment market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Muscle Invasive Bladder Cancer Treatment market.

Global Muscle Invasive Bladder Cancer Treatment Scope and Market Size
Muscle Invasive Bladder Cancer Treatment market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Muscle Invasive Bladder Cancer Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Neo-adjuvant Chemotherapy
Post-operative Chemotherapy

Segment by Application
Hospital
Research Institute
Specialist Clinic

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Pfizer Inc
Mylan N.V.
Cadila Pharmaceuticals
GLS pharma Ltd.
Accord Healthcare
Novartis AG
Cipla Inc.
Biochem Pharma

レポート目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Muscle Invasive Bladder Cancer Treatment Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Neo-adjuvant Chemotherapy
1.2.3 Post-operative Chemotherapy
1.3 Market by Application
1.3.1 Global Muscle Invasive Bladder Cancer Treatment Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital
1.3.3 Research Institute
1.3.4 Specialist Clinic
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Muscle Invasive Bladder Cancer Treatment Market Perspective (2016-2027)
2.2 Muscle Invasive Bladder Cancer Treatment Growth Trends by Regions
2.2.1 Muscle Invasive Bladder Cancer Treatment Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Muscle Invasive Bladder Cancer Treatment Historic Market Share by Regions (2016-2021)
2.2.3 Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Regions (2022-2027)
2.3 Muscle Invasive Bladder Cancer Treatment Industry Dynamic
2.3.1 Muscle Invasive Bladder Cancer Treatment Market Trends
2.3.2 Muscle Invasive Bladder Cancer Treatment Market Drivers
2.3.3 Muscle Invasive Bladder Cancer Treatment Market Challenges
2.3.4 Muscle Invasive Bladder Cancer Treatment Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Muscle Invasive Bladder Cancer Treatment Players by Revenue
3.1.1 Global Top Muscle Invasive Bladder Cancer Treatment Players by Revenue (2016-2021)
3.1.2 Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Players (2016-2021)
3.2 Global Muscle Invasive Bladder Cancer Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Muscle Invasive Bladder Cancer Treatment Revenue
3.4 Global Muscle Invasive Bladder Cancer Treatment Market Concentration Ratio
3.4.1 Global Muscle Invasive Bladder Cancer Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Muscle Invasive Bladder Cancer Treatment Revenue in 2020
3.5 Muscle Invasive Bladder Cancer Treatment Key Players Head office and Area Served
3.6 Key Players Muscle Invasive Bladder Cancer Treatment Product Solution and Service
3.7 Date of Enter into Muscle Invasive Bladder Cancer Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Muscle Invasive Bladder Cancer Treatment Breakdown Data by Type
4.1 Global Muscle Invasive Bladder Cancer Treatment Historic Market Size by Type (2016-2021)
4.2 Global Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Type (2022-2027)

5 Muscle Invasive Bladder Cancer Treatment Breakdown Data by Application
5.1 Global Muscle Invasive Bladder Cancer Treatment Historic Market Size by Application (2016-2021)
5.2 Global Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Muscle Invasive Bladder Cancer Treatment Market Size (2016-2027)
6.2 North America Muscle Invasive Bladder Cancer Treatment Market Size by Type
6.2.1 North America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021)
6.2.2 North America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027)
6.2.3 North America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2027)
6.3 North America Muscle Invasive Bladder Cancer Treatment Market Size by Application
6.3.1 North America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021)
6.3.2 North America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027)
6.3.3 North America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2027)
6.4 North America Muscle Invasive Bladder Cancer Treatment Market Size by Country
6.4.1 North America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021)
6.4.2 North America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Muscle Invasive Bladder Cancer Treatment Market Size (2016-2027)
7.2 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type
7.2.1 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021)
7.2.2 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027)
7.2.3 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2027)
7.3 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application
7.3.1 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021)
7.3.2 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027)
7.3.3 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2027)
7.4 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Country
7.4.1 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021)
7.4.2 Europe Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size (2016-2027)
8.2 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type
8.2.1 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2027)
8.3 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application
8.3.1 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2027)
8.4 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Region
8.4.1 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Muscle Invasive Bladder Cancer Treatment Market Size (2016-2027)
9.2 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type
9.2.1 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021)
9.2.2 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027)
9.2.3 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2027)
9.3 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application
9.3.1 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021)
9.3.2 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027)
9.3.3 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2027)
9.4 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Country
9.4.1 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021)
9.4.2 Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size (2016-2027)
10.2 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type
10.2.1 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2027)
10.3 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application
10.3.1 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2027)
10.4 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Country
10.4.1 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Pfizer Inc
11.1.1 Pfizer Inc Company Details
11.1.2 Pfizer Inc Business Overview
11.1.3 Pfizer Inc Muscle Invasive Bladder Cancer Treatment Introduction
11.1.4 Pfizer Inc Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.1.5 Pfizer Inc Recent Development
11.2 Mylan N.V.
11.2.1 Mylan N.V. Company Details
11.2.2 Mylan N.V. Business Overview
11.2.3 Mylan N.V. Muscle Invasive Bladder Cancer Treatment Introduction
11.2.4 Mylan N.V. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.2.5 Mylan N.V. Recent Development
11.3 Cadila Pharmaceuticals
11.3.1 Cadila Pharmaceuticals Company Details
11.3.2 Cadila Pharmaceuticals Business Overview
11.3.3 Cadila Pharmaceuticals Muscle Invasive Bladder Cancer Treatment Introduction
11.3.4 Cadila Pharmaceuticals Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.3.5 Cadila Pharmaceuticals Recent Development
11.4 GLS pharma Ltd.
11.4.1 GLS pharma Ltd. Company Details
11.4.2 GLS pharma Ltd. Business Overview
11.4.3 GLS pharma Ltd. Muscle Invasive Bladder Cancer Treatment Introduction
11.4.4 GLS pharma Ltd. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.4.5 GLS pharma Ltd. Recent Development
11.5 Accord Healthcare
11.5.1 Accord Healthcare Company Details
11.5.2 Accord Healthcare Business Overview
11.5.3 Accord Healthcare Muscle Invasive Bladder Cancer Treatment Introduction
11.5.4 Accord Healthcare Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.5.5 Accord Healthcare Recent Development
11.6 Novartis AG
11.6.1 Novartis AG Company Details
11.6.2 Novartis AG Business Overview
11.6.3 Novartis AG Muscle Invasive Bladder Cancer Treatment Introduction
11.6.4 Novartis AG Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.6.5 Novartis AG Recent Development
11.7 Cipla Inc.
11.7.1 Cipla Inc. Company Details
11.7.2 Cipla Inc. Business Overview
11.7.3 Cipla Inc. Muscle Invasive Bladder Cancer Treatment Introduction
11.7.4 Cipla Inc. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.7.5 Cipla Inc. Recent Development
11.8 Biochem Pharma
11.8.1 Biochem Pharma Company Details
11.8.2 Biochem Pharma Business Overview
11.8.3 Biochem Pharma Muscle Invasive Bladder Cancer Treatment Introduction
11.8.4 Biochem Pharma Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
11.8.5 Biochem Pharma Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Muscle Invasive Bladder Cancer Treatment Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Neo-adjuvant Chemotherapy
Table 3. Key Players of Post-operative Chemotherapy
Table 4. Global Muscle Invasive Bladder Cancer Treatment Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Muscle Invasive Bladder Cancer Treatment Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Muscle Invasive Bladder Cancer Treatment Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Muscle Invasive Bladder Cancer Treatment Market Share by Regions (2016-2021)
Table 8. Global Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Muscle Invasive Bladder Cancer Treatment Market Share by Regions (2022-2027)
Table 10. Muscle Invasive Bladder Cancer Treatment Market Trends
Table 11. Muscle Invasive Bladder Cancer Treatment Market Drivers
Table 12. Muscle Invasive Bladder Cancer Treatment Market Challenges
Table 13. Muscle Invasive Bladder Cancer Treatment Market Restraints
Table 14. Global Muscle Invasive Bladder Cancer Treatment Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Muscle Invasive Bladder Cancer Treatment Market Share by Players (2016-2021)
Table 16. Global Top Muscle Invasive Bladder Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Invasive Bladder Cancer Treatment as of 2020)
Table 17. Ranking of Global Top Muscle Invasive Bladder Cancer Treatment Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Muscle Invasive Bladder Cancer Treatment Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Muscle Invasive Bladder Cancer Treatment Product Solution and Service
Table 21. Date of Enter into Muscle Invasive Bladder Cancer Treatment Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Type (2016-2021)
Table 25. Global Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Muscle Invasive Bladder Cancer Treatment Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Application (2016-2021)
Table 29. Global Muscle Invasive Bladder Cancer Treatment Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size by Country (2022-2027) & (US$ Million)
Table 61. Pfizer Inc Company Details
Table 62. Pfizer Inc Business Overview
Table 63. Pfizer Inc Muscle Invasive Bladder Cancer Treatment Product
Table 64. Pfizer Inc Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 65. Pfizer Inc Recent Development
Table 66. Mylan N.V. Company Details
Table 67. Mylan N.V. Business Overview
Table 68. Mylan N.V. Muscle Invasive Bladder Cancer Treatment Product
Table 69. Mylan N.V. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 70. Mylan N.V. Recent Development
Table 71. Cadila Pharmaceuticals Company Details
Table 72. Cadila Pharmaceuticals Business Overview
Table 73. Cadila Pharmaceuticals Muscle Invasive Bladder Cancer Treatment Product
Table 74. Cadila Pharmaceuticals Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 75. Cadila Pharmaceuticals Recent Development
Table 76. GLS pharma Ltd. Company Details
Table 77. GLS pharma Ltd. Business Overview
Table 78. GLS pharma Ltd. Muscle Invasive Bladder Cancer Treatment Product
Table 79. GLS pharma Ltd. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 80. GLS pharma Ltd. Recent Development
Table 81. Accord Healthcare Company Details
Table 82. Accord Healthcare Business Overview
Table 83. Accord Healthcare Muscle Invasive Bladder Cancer Treatment Product
Table 84. Accord Healthcare Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 85. Accord Healthcare Recent Development
Table 86. Novartis AG Company Details
Table 87. Novartis AG Business Overview
Table 88. Novartis AG Muscle Invasive Bladder Cancer Treatment Product
Table 89. Novartis AG Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 90. Novartis AG Recent Development
Table 91. Cipla Inc. Company Details
Table 92. Cipla Inc. Business Overview
Table 93. Cipla Inc. Muscle Invasive Bladder Cancer Treatment Product
Table 94. Cipla Inc. Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 95. Cipla Inc. Recent Development
Table 96. Biochem Pharma Company Details
Table 97. Biochem Pharma Business Overview
Table 98. Biochem Pharma Revenue in Muscle Invasive Bladder Cancer Treatment Business (2016-2021) & (US$ Million)
Table 99. Biochem Pharma Recent Development
Table 100. Research Programs/Design for This Report
Table 101. Key Data Information from Secondary Sources
Table 102. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Muscle Invasive Bladder Cancer Treatment Market Share by Type: 2020 VS 2027
Figure 2. Neo-adjuvant Chemotherapy Features
Figure 3. Post-operative Chemotherapy Features
Figure 4. Global Muscle Invasive Bladder Cancer Treatment Market Share by Application: 2020 VS 2027
Figure 5. Hospital Case Studies
Figure 6. Research Institute Case Studies
Figure 7. Specialist Clinic Case Studies
Figure 8. Muscle Invasive Bladder Cancer Treatment Report Years Considered
Figure 9. Global Muscle Invasive Bladder Cancer Treatment Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Muscle Invasive Bladder Cancer Treatment Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Muscle Invasive Bladder Cancer Treatment Market Share by Regions: 2020 VS 2027
Figure 12. Global Muscle Invasive Bladder Cancer Treatment Market Share by Regions (2022-2027)
Figure 13. Global Muscle Invasive Bladder Cancer Treatment Market Share by Players in 2020
Figure 14. Global Top Muscle Invasive Bladder Cancer Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Muscle Invasive Bladder Cancer Treatment as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Muscle Invasive Bladder Cancer Treatment Revenue in 2020
Figure 16. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Type (2016-2021)
Figure 17. Global Muscle Invasive Bladder Cancer Treatment Revenue Market Share by Type (2022-2027)
Figure 18. North America Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Muscle Invasive Bladder Cancer Treatment Market Share by Type (2016-2027)
Figure 20. North America Muscle Invasive Bladder Cancer Treatment Market Share by Application (2016-2027)
Figure 21. North America Muscle Invasive Bladder Cancer Treatment Market Share by Country (2016-2027)
Figure 22. United States Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Muscle Invasive Bladder Cancer Treatment Market Share by Type (2016-2027)
Figure 26. Europe Muscle Invasive Bladder Cancer Treatment Market Share by Application (2016-2027)
Figure 27. Europe Muscle Invasive Bladder Cancer Treatment Market Share by Country (2016-2027)
Figure 28. Germany Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Muscle Invasive Bladder Cancer Treatment Market Share by Region (2016-2027)
Figure 38. China Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Muscle Invasive Bladder Cancer Treatment Market Share by Type (2016-2027)
Figure 46. Latin America Muscle Invasive Bladder Cancer Treatment Market Share by Application (2016-2027)
Figure 47. Latin America Muscle Invasive Bladder Cancer Treatment Market Share by Country (2016-2027)
Figure 48. Mexico Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Muscle Invasive Bladder Cancer Treatment Market Share by Country (2016-2027)
Figure 54. Turkey Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Muscle Invasive Bladder Cancer Treatment Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Pfizer Inc Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 58. Mylan N.V. Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 59. Cadila Pharmaceuticals Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 60. GLS pharma Ltd. Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 61. Accord Healthcare Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 62. Novartis AG Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 63. Cipla Inc. Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 64. Biochem Pharma Revenue Growth Rate in Muscle Invasive Bladder Cancer Treatment Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

以下、関連資料のご紹介

世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年）

Global Bladder Cancer Molecular Diagnostics Market Size, Status and Forecast 2021-2027
QFJ1-3914 2021年6月 98Pages
QYResearch社発行の本調査レポートでは、膀胱がん分子病理学診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究所）、主要地域別市場規模...

世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3803 2021年6月 85Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南...

世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年）

Global Metastatic Pancreatic Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4499 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、転移性膵がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、標的療法、その他）、用途別市場規模（外分泌、内分泌）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、イン...

世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年）

Global Castrate-resistant Prostate Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-3976 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、去勢抵抗性前立腺がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（化学療法、ホルモン療法、免疫療法、放射線療法）、用途別市場規模（病院、診療所、その他）、主要地域別市場規模（北米、アメリカ、欧州...

世界の精巣がん治療市場規模・現状・予測（2021年-2027年）

Global Testicular Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-4948 2021年6月 99Pages
QYResearch社発行の本調査レポートでは、精巣がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（注射剤、経口剤）、用途別市場規模（病院薬局、小売薬局、専門がんクリニック、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、...

世界のOAB治療市場規模・現状・予測（2021年-2027年）

Global OAB Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5902 2021年6月 96Pages
QYResearch社発行の本調査レポートでは、OAB治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（抗コリン作用薬、ミラベグロン、ボトックス）、用途別市場規模（特発性過活動膀胱、神経性過活動膀胱）、主要地域別市場規模（北米、アメリカ、欧州、ア...

世界の腎細胞がん治療市場規模・現状・予測（2021年-2027年）

Global Renal Cell Cancer Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5989 2021年6月 118Pages
QYResearch社発行の本調査レポートでは、腎細胞がん治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（モノクローナル抗体、mTOR阻害剤、キナーゼ阻害剤、その他）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧...

世界の家族性大腸腺腫症治療市場規模・現状・予測（2021年-2027年）

Global Familial Adenomatous Polyposis Treatment Market Size, Status and Forecast 2021-2027
QFJ1-5736 2021年6月 89Pages
QYResearch社発行の本調査レポートでは、家族性大腸腺腫症治療の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（イコサペント、塩酸エフロルニチン、アスピリン、CEQ-508、その他）、用途別市場規模（診療所、病院、その他）、主要地域別市場規模（...

世界の未分化甲状腺がん市場規模・現状・予測（2021年-2027年）

Global Anaplastic Thyroid Cancer Market Size, Status and Forecast 2021-2027
QFJ1-3801 2021年6月 88Pages
QYResearch社発行の本調査レポートでは、未分化甲状腺がんの世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（経口、注射）、用途別市場規模（病院、薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジ...

世界の口腔がん分子診断市場規模・現状・予測（2021年-2027年）

Global Oral Cancer Molecular Diagnosis Market Size, Status and Forecast 2021-2027
QFJ1-4622 2021年6月 86Pages
QYResearch社発行の本調査レポートでは、口腔がん分子診断の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（PCR、FISH、DNAシーケンシング、ジーンチップ）、用途別市場規模（臨床診断、薬物スクリーニング、研究）、主要地域別市場規模（北米、...

世界の膀胱がん分子病理学診断市場規模・現状・予測（2021年-2027年） A molecular approach for diagnosing bladder cancer Market Analysis and Insights: Global Bladder Cancer Molecular Diagnostics Market The global Bladder Cancer Molecular Diagnostics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027…
世界の未分化甲状腺がん治療市場規模・現状・予測（2021年-2027年） Anaplastic thyroid cancer is one of four types ofthyroid cancer. It's very rare: The American ThyroidAssociation notes that this type represents less than 2 percent of all cases of thyroid cancer. Market Analysis and Insights: Global Anaplastic Thyroid Cancer Treatment Market The global Anaplastic T…
世界の去勢抵抗性前立腺がん治療市場規模・現状・予測（2021年-2027年） Prostate cancer that keeps growing even when the amount of testosterone in the body is reduced to very low levels. Many early-stage prostate cancers need normal levels of testosterone to grow, but castrate-resistant prostate cancers do not. Also called CRPC. Market Analysis and Insights: Global Cast…
世界の転移性膵がん治療市場規模・現状・予測（2021年-2027年） Metastatic pancreatic cancer treatment, when cancer spreads outside of the pancreas, surgery may or may not be recommended. It’s more common for oncologists to recommend systemic treatments (which can circulate throughout the entire body and destroy cancerous cells in multiple locations) for metasta…
世界の精巣がん治療市場規模・現状・予測（2021年-2027年） Testicular cancer is one of the most common tumors in urology. Testicular tumors are divided into primary and secondary, most of which are primary, and secondary is extremely rare. Most are malignant tumors, so treatment drugs are important. Market Analysis and Insights: Global Testicular Cancer Tre…